NCAM1 and relapsing-remitting multiple sclerosis: For instance, a population of of CD8low+CD4− cells was recently identified in untreated RRMS patients, as well as in individuals with a clinically isolated demyelation syndrome; these differences had been attributed to a reduction in CD8low+CD56+CD3− natural killer cells [4].